Effects of Soy Isoflavone on Bone Health Among Saudi Female Students Imam Abdulrahman Bin Faisal University.
1 other identifier
interventional
28
1 country
1
Brief Summary
Low bone mineral density (BMD) has recently increased among young women. Soy Isoflavone as a food supplement, has been found to have potent effect on bone health in postmenopausal women. However, the effect of soy isoflavone on pre-menopausal is not well understood. This research is done to examine the effect of soy isoflavones on BMD among young university female students.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Dec 2018
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2019
CompletedFirst Submitted
Initial submission to the registry
September 6, 2020
CompletedFirst Posted
Study publicly available on registry
September 14, 2020
CompletedSeptember 28, 2023
September 1, 2023
3 months
September 6, 2020
September 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Bone Mineral Density (BMD)
4 weeks
Study Arms (1)
Intervention group
EXPERIMENTALIn four weeks of intervention study the participants instructed to receive (60 mg) of soy-isoflavone supplement per day, after this period the Bone Mineral Density was assessed by Dual X-ray Absorptiometry scan to evaluate the effect of soy-isoflavone supplement on Bone mineral density.
Interventions
Participants received 60 mg of soy-isoflavone supplement per day.
Eligibility Criteria
You may qualify if:
- female
- University students
- aged between 18-25 years
You may not qualify if:
- Study participants who use medications and suffer from diseases that may interfere or effect on BMD, use calcium and vitamin D supplements and who suffer from glucose 6 phosphate deficiency (G6PD) were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imam Abdulrahman Bin Faisal University
Dammam, Eastern Province, 34221, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 6, 2020
First Posted
September 14, 2020
Study Start
December 12, 2018
Primary Completion
March 15, 2019
Study Completion
March 15, 2019
Last Updated
September 28, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share